Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human TrialsMindMed Reports Full Year 2022 Financial Results and Business HighlightsCybin to Participate in the Oppenheimer 33rd Annual Healthcare ConferenceNuminus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023Irwin Naturals Signs Letter of Intent to Acquire Braxia ScientificNuminus Wellness Inc. Reports Q1 2023 ResultsIrwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical CompanNuminus Develops Mushroom Tea for Use in Psychedelic ResearchIs the Psychedelic Sector Poised for a Comeback?!?PSYC + Nucleus Form New Partnership to Develop and Launch Psychedelic FinderWhat You Need to Know About Numinus Wellness…Numinus provides update on acquisition integration and announces new client financing optionsPSYC Corp’s Psychedelic Spotlight Surpasses One Million Page Views for Fourth Consecutive MonthNuminus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022The Psychedelic Sector is Quietly Outperforming the S&P 500PSYC Completes and Publishes 2021 Audited Financials; Will Begin Audit of Q1 & Q2 2022Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022PSYC’s Bonfire Platform Development Progresses; Will Host Free Virtual Community Event on August 29th

3 Largest Funds Invested In Aurora Cannabis, Aphria, and Canopy Growth

Oct 24, 2017 • 1:06 PM EDT
Canada Stocks (96).png
1 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

Although Canada’s medical marijuana market is one of the most attractive investment opportunities available, the market has been dominated by retail investors.

While the lack of institutional capital has kept several major investment firms on the sidelines with the legal cannabis industry, we have seen some initiations enter this market.

Which Institutions are Investing in Canadian Cannabis Producers?

We have highlighted the three largest investment funds that are invested in three of the largest Canadian licensed medical marijuana producers. This data was found through the Thomson Reuters Eikon platform and is current as of today.

Canopy Growth Corp (WEED.TO) (TWMJF)

  1. Fidelity Institutional Asset Management – 1.95 million shares (1.14%)
  2. Horizons ETFs Management (Canada) Inc. – 1.53 million shares (0.89%)
  3. BlackRock Institutional Trust Company – 400,000 shares (0.23%)

Aurora Cannabis (ACB.TO) (ACBFF)

  1. Private Alberta Company – 15.09 million shares (4.02%)
  2. Lola Ventures Inc. – 11.99 million shares (3.2%)
  3. Horizons ETFs Management (Canada) Inc. – 5.7 million shares (1.52%)

Aphria Inc. (APH.TO) (APHQF)

  1. MM Asset Management – 3.15 million shares (2.27%)
  2. Horizons ETFs Management (Canada) Inc. – 2.23 million shares (1.6%)
  3. Manulife Asset Management Limited -1.42 million shares (1.02%)
Share Share - Facebook Share - Twitter


Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.


Top Stories

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Mushroomstocks newsletter.

 All good -- no spamming here.

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.